New insights into SUMOylation and NEDDylation in fibrosis
2024

New insights into SUMOylation and NEDDylation in fibrosis

publication Evidence: moderate

Author Information

Author(s): Han Jin, Wu Jun, Kou Wen-Tao, Xie Li-Na, Tang Ya-Li, Zhi Da-Long, Li Ping, Chen Dan-Qian

Primary Institution: Northwest University Chang An Hospital, Faculty of Life Sciences and Medicine, Northwest University, Xi’an, Shaanxi, China

Hypothesis

SUMOylation and NEDDylation play pivotal roles in organ fibrosis and can be targeted for therapeutic interventions.

Conclusion

The review highlights the therapeutic potentials of SUMOylation and NEDDylation in treating organ fibrosis.

Supporting Evidence

  • SUMOylation and NEDDylation are involved in the regulation of fibrosis through various cellular mechanisms.
  • Therapeutic potentials of SUMOylation/NEDDylation activators and inhibitors against organ fibrosis have been highlighted.
  • Further investigations are needed to identify novel substrates and therapeutic effects of these modifications.

Takeaway

This study talks about how two special processes in our cells, SUMOylation and NEDDylation, can help us understand and treat diseases where our organs get damaged and scarred.

Methodology

This is a review article summarizing recent findings on the roles of SUMOylation and NEDDylation in organ fibrosis.

Limitations

The review notes the limited number of clinical and preclinical investigations on SUMOylation/NEDDylation activators and inhibitors.

Digital Object Identifier (DOI)

10.3389/fphar.2024.1476699

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication